RU96123569A - Лекарственный препарат - Google Patents

Лекарственный препарат

Info

Publication number
RU96123569A
RU96123569A RU96123569/14A RU96123569A RU96123569A RU 96123569 A RU96123569 A RU 96123569A RU 96123569/14 A RU96123569/14 A RU 96123569/14A RU 96123569 A RU96123569 A RU 96123569A RU 96123569 A RU96123569 A RU 96123569A
Authority
RU
Russia
Prior art keywords
medicinal product
zinc
zinc sulfate
diazoline
tetrahydrocarboline
Prior art date
Application number
RU96123569/14A
Other languages
English (en)
Other versions
RU2121347C1 (ru
Inventor
П.В. Сергеев
Н.Л. Шимановский
Original Assignee
Закрытое акционерное общество Акционерная внешнеэкономическая компания "ЭКСИМА"
П.В. Сергеев
Н.Л. Шимановский
Filing date
Publication date
Application filed by Закрытое акционерное общество Акционерная внешнеэкономическая компания "ЭКСИМА", П.В. Сергеев, Н.Л. Шимановский filed Critical Закрытое акционерное общество Акционерная внешнеэкономическая компания "ЭКСИМА"
Priority to RU96123569A priority Critical patent/RU2121347C1/ru
Priority claimed from RU96123569A external-priority patent/RU2121347C1/ru
Priority to UA97126465A priority patent/UA26946C2/ru
Application granted granted Critical
Publication of RU2121347C1 publication Critical patent/RU2121347C1/ru
Publication of RU96123569A publication Critical patent/RU96123569A/ru

Links

Claims (2)

1. Лекарственный препарат, содержащий 3-метил- 9-бензил- 1, 2, 3, 4-тетрагидрокарболина нафталин- 1, 5-дисульфонат, отличающийся тем, что в состав препарата дополнительно вводят использовавшиеся в медицинской практике официнальные соли цинка - цинка сульфат, цинка аспартат в количестве по весу от 1 : 20 до 1 : 25.
2. Лекарственный препарат, отличающийся тем, что в состав таблетки вводят цинка сульфат при соотношении ингредиентов, г:
Диазолина - 0,4-0,2
Цинка сульфата - 0,02-0,01
Вспомогательных веществ до массы - 0,5-0,25
RU96123569A 1996-12-15 1996-12-15 Лекарственный препарат RU2121347C1 (ru)

Priority Applications (2)

Application Number Priority Date Filing Date Title
RU96123569A RU2121347C1 (ru) 1996-12-15 1996-12-15 Лекарственный препарат
UA97126465A UA26946C2 (ru) 1996-12-15 1997-12-12 Антигистаминный лекарственный препарат

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU96123569A RU2121347C1 (ru) 1996-12-15 1996-12-15 Лекарственный препарат

Publications (2)

Publication Number Publication Date
RU2121347C1 RU2121347C1 (ru) 1998-11-10
RU96123569A true RU96123569A (ru) 1999-01-27

Family

ID=20188113

Family Applications (1)

Application Number Title Priority Date Filing Date
RU96123569A RU2121347C1 (ru) 1996-12-15 1996-12-15 Лекарственный препарат

Country Status (2)

Country Link
RU (1) RU2121347C1 (ru)
UA (1) UA26946C2 (ru)

Similar Documents

Publication Publication Date Title
CA2253980A1 (en) Locally administrable, biodegradable and sustained-release pharmaceutical composition for periodontitis and process for preparation thereof
IL111647A0 (en) Microencapsulated 3-piperidinyl-substituted 1,2-benzisoxazoles and 1,2-benzisothiazoles, their preparation and pharmaceutical compositions containing them
IS1694B (is) Lyfjablanda til að gefa dýrum um munn sem inniheldur prótonupumpublokkara
IL86827A (en) Press coated tablets containing dihydropyridines and their preparation
NZ516347A (en) Indanyl-substituted benzenecarboxamides, process for their preparation, their use as a medicament and pharmaceutical formulations containing them
AU7848187A (en) Pharmaceutical formulations
IL80149A (en) Pharmaceutical compositions containing toluidide derivatives against graft-versus-host diseases and autoimmune diseases
FR2698788B1 (fr) Composition pharmaceutique effervescente contenant de l'ibuprofène et son procédé de préparation.
IL58697A0 (en) Analgesic pharmaceutical compositions in the form of effervescent powders comprising metoclopramide
NL193440C (nl) Farmaceutisch preparaat met analgetische werking.
CA2202397A1 (en) Compositions comprising carbonate/bicarbonate buffered dichloroacetic acid and methods for treatment of metabolic and cardiovascular disorders
ATE220321T1 (de) Feste flupirtin enthaltende orale darreichungsformen mit kontrollierter wirkstoffabgabe
CA2383212A1 (en) Controlled release oral dosage suitable for oral administration
CA2038744A1 (en) Pharmaceutical composition containing slightly water-soluble drug
IL103329A0 (en) Imidazole-5-carboxylic acid acylals,their preparation and pharmaceutical compositions containing them
ZA881181B (en) Process for preparing a retard product containing diltiazem for a single daily administration
DE60006362D1 (de) Kapseln mit loratadin und pseudoephedrin enthaltenden zusammensetzungen
MY129946A (en) Compound with gastric acid inhibitory effect and process for its preparation.
CA2105541A1 (en) Programmed Release Tablets Containing Naproxen
FR2712809B1 (fr) Nouvelle composition pharmaceutique destinée à la préparation d'une poudre stable contenant, à titre d'ingrédient actif, une association d'acide acétylsalicylique et de métoclopramide.
CA2078869A1 (en) Pharmaceutical compositions containing ipriflavone, process for the preparation thereof and relative therapeutic use
IL102032A0 (en) 2-amino-5-cyano-1,4-dihydropyridines,their preparation and pharmaceutical compositions containing them
RU96123569A (ru) Лекарственный препарат
KR890001559A (ko) 트라피딜을 함유하는 제약 조성물, 그의 제조방법 및 관련된 치료 용도
MY102368A (en) Solid sustained-release composition